Cargando…

EP4-mediated prostanoid signalling promotes oral cancer progression

Detalles Bibliográficos
Autores principales:	Sapienza, Karen, Sale, Stewart, Hague, Angela, Hart, Ian R, Marshall, John F, Thomas, Gareth J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255032/

Ejemplares similares

Expression of Prostanoid EP3 Receptors in Oral Squamous Epithelium and Oral Squamous Cell Carcinoma
por: Kashif, Muhammad, et al.
Publicado: (2015)

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
por: Philipose, Sonia, et al.
Publicado: (2012)

The Gαs‐protein‐mediated pathway may be steadily stimulated by prostanoid EP2 receptors, but not by EP4 receptors
por: Fukushima, Keijo, et al.
Publicado: (2022)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

Improved homology modeling of the human & rat EP(4) prostanoid receptors
por: Holt, Melissa C., et al.
Publicado: (2019)

Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014)

Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
por: Bao, Xingfeng, et al.
Publicado: (2015)

Does IgE-mediated mast cell activation reduce oral tolerance to food antigens?
por: Tunis, M, et al.
Publicado: (2010)

Performance of self-reported adherence to oral pre-exposure prophylaxis (PrEP) among HIV heterosexual serodiscordant couples in rural Uganda
por: Kibengo, FM, et al.
Publicado: (2012)

Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke
por: Frankowski, Jan C., et al.
Publicado: (2015)

The affinity, intrinsic activity and selectivity of a structurally novel EP(2) receptor agonist at human prostanoid receptors
por: Coleman, R A, et al.
Publicado: (2019)

De novo expression of α(v)β(6 )integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression
por: Allen, M, et al.
Publicado: (2008)

Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model
por: Masato, Masahito, et al.
Publicado: (2021)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

Physiology and pathophysiology of prostanoid receptors
por: Narumiya, Shuh
Publicado: (2007)

Role of protein kinase B in breast cancer
por: Sale, EM, et al.
Publicado: (2006)

Expression of prostaglandin E(2) prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma – preliminary study
por: Mochocki, Marcin, et al.
Publicado: (2015)

Suppression of polyi:c-inducible gene expression by EP3 in murine conjunctival epithelium
por: Ueta, Mayumi, et al.
Publicado: (2014)

Intra-cardiac MR imaging & MR-tracking catheter for improved MR-guided EP
por: Chen, Yue, et al.
Publicado: (2015)

Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
por: Schmid, Tobias, et al.
Publicado: (2021)

Nicotine induces EP4 receptor expression in lung carcinoma cells by acting on AP-2α: The intersection between cholinergic and prostanoid signaling
por: Fan, Yu, et al.
Publicado: (2017)

Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
por: Li, Zhenhua, et al.
Publicado: (2017)

Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
por: Hikage, Fumihito, et al.
Publicado: (2021)

Prostanoid Receptors in the Human Vascular Wall
por: Norel, Xavier
Publicado: (2007)

Prostanoid Metabolites as Biomarkers in Human Disease
por: Idborg, Helena, et al.
Publicado: (2022)

The Link between Prostanoids and Cardiovascular Diseases
por: Beccacece, Livia, et al.
Publicado: (2023)

First clinical experience in man with the IMRICOR-MR-EP system:Electrophysiology study guided by real-time MRI
por: Gutberlet, Matthias, et al.
Publicado: (2012)

Co-Stimulation of Purinergic P2X4 and Prostanoid EP3 Receptors Triggers Synergistic Degranulation in Murine Mast Cells
por: Yoshida, Kazuki, et al.
Publicado: (2019)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
por: Bayingana, R, et al.
Publicado: (2012)

Sphingosine-1 phosphate promotes thymic atrophy during sepsis progression
por: Kuchler, L, et al.
Publicado: (2014)

Transitioning Stable Patients with Pulmonary Arterial Hypertension from Parenteral Prostanoids to Oral Selexipag
por: Hinkamp, Colin, et al.
Publicado: (2022)

The Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity
por: Harizi, Hedi
Publicado: (2013)

Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors
por: Ershov, Pavel V., et al.
Publicado: (2022)

The role of thromboxane prostanoid receptor signaling in gastric ulcer healing
por: Yamane, Sakiko, et al.
Publicado: (2021)

P163 Slow wave transcranial electrical stimulation during wake to investigate the consolidation of new learning
por: Wood, J, et al.
Publicado: (2021)

HIV pre-exposure prophylaxis (PrEP)- knowledge and attitudes among a New York City emergency department patient population
por: Calderon, Yvette, et al.
Publicado: (2012)

P19-15. Synthesis of multivalent mimotopes as potential vaccine candidates
por: Go, JG, et al.
Publicado: (2009)

Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy
por: Chen, X.-B., et al.
Publicado: (2005)

Prostanoid therapies in the management of pulmonary arterial hypertension
por: LeVarge, Barbara L
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qt26hce3dpt2da5lkudl0ohjah